Tag: Dana-Farber Cancer Institute
Dr. Matthew H. Kulke to be Featured Guest for CCF’s Luncheon with the Experts
Matthew H. Kulke, MD, medical oncologist and hematologist, will be the featured guest for CCF’s Facebook Live Luncheon with the Experts on Thursday, May 27 from 12 noon to 1 pm, Eastern Time. Dr. Kulke is the Chief of Hematology/Oncology, Co-Director …
READ MORENeuroendocrine Tumors Focus of Upcoming Issue of Hematology/Oncology Clinics
Neuroendocrine Tumors will be featured in the February 2016 issue of Hematology/Oncology Clinics. Dr. Jennifer Chan and Dr. Matthew Kulke, both from Dana-Farber Cancer Institute in Boston, Massachusetts are Editors of the issue, published by Elsevier.…
READ MORELexicon’s Carcinoid Syndrome Treatment Meets Primary Endpoint in Phase III Clinical Trial
Lexicon Pharmaceuticals Inc. has announced that the pivotal phase III clinical trial, TELESTAR, of its oral drug candidate telotristat etiprate met the primary endpoint in treating cancer patients with carcinoid syndrome that is not adequately controlled…
READ MORE10 Highlights for the Carcinoid and Neuroendocrine Tumor Community
- PET/CT using Gallium-68 DOTATOC captures hidden source of neuroendocrine cancer. “An investigational molecular imaging technique could be the key to finding the elusive primary tumor, say presenters at the 2015 Annual Meeting of the Society
Clinical Trial for GI Carcinoid Patients Recruiting Through September
Gastrointestinal carcinoid patients who have tumors that either are not suitable for standard treatment or are not responding to standard treatment have the opportunity to enroll in a Phase I/II clinical trial conducted by Tekmira Pharmaceuticals…
READ MORENew England Carcinoid Connection Announces June 2014 Conference for the Carcinoid and Neuroendocrine Tumor Community
Carcinoid and neuroendocrine cancer patients, family members, caregivers, and healthcare professionals are invited to attend the New England Carcinoid Connection Conference on Friday, June 27, 2014 at The Lantana in Randolph, Massachusetts. The…
READ MOREOncLive TV Releases 2 More Videos in Neuroendocrine Tumors Series
Two new videos have been released in the OncLive TV series on carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors, and genetic syndromes that predispose people to develop pancreatic NETs such MEN1 (multiple endocrine…
READ MORENew OncLive TV Series Focuses on Neuroendocrine Tumors
Carcinoid and neuroendocrine tumors (NETs), including pancreatic neuroendocrine tumors and even more uncommon NETs such as goblet cell carcinoid and mixed adenocarcinomas, are discussed by a panel of medical experts in this new video series from …
READ MORENew England Carcinoid Connection (NECC) Announces June 2012 Conference
Carcinoid and neuroendocrine cancer patients, family members, caregivers, and healthcare professionals are invited to attend the New England Carcinoid Connection Conference on Friday, June 8, 2012 at The Lantana in Randolph, Massachusetts. The…
READ MORENeuroendocrine Tumors Featured on Healthy Body, Healthy Mind Television Series
For a comprehensive overview of neuroendocrine tumors, watch this fascinating video on the Healthy Body, Healthy Mind television series. Every episode on the health and wellness TV series focuses on the stories of real people; people who are working…
READ MORE